Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

116 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects.
Hartmann JT, Haap M, Kopp HG, Lipp HP. Hartmann JT, et al. Among authors: kopp hg. Curr Drug Metab. 2009 Jun;10(5):470-81. doi: 10.2174/138920009788897975. Curr Drug Metab. 2009. PMID: 19689244 Review.
Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases.
Kopp HG, Krauss K, Fehm T, Staebler A, Zahm J, Vogel W, Kanz L, Mayer F. Kopp HG, et al. Anticancer Res. 2011 Nov;31(11):4025-30. Anticancer Res. 2011. PMID: 22110237
Advances in the treatment of testicular cancer.
Kopp HG, Kuczyk M, Classen J, Stenzl A, Kanz L, Mayer F, Bamberg M, Hartmann JT. Kopp HG, et al. Drugs. 2006;66(5):641-59. doi: 10.2165/00003495-200666050-00005. Drugs. 2006. PMID: 16620142 Review.
Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
Kopp HG, Patel S, Brücher B, Hartmann JT. Kopp HG, et al. Am J Clin Dermatol. 2008;9(4):207-17. doi: 10.2165/00128071-200809040-00001. Am J Clin Dermatol. 2008. PMID: 18572972 Review.
The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents.
Betz M, Kopp HG, Spira D, Claussen CD, Horger M. Betz M, et al. Among authors: kopp hg. Acta Radiol. 2013 Sep;54(7):711-21. doi: 10.1177/0284185113484642. Epub 2013 May 12. Acta Radiol. 2013. PMID: 23761542 Review.
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide.
Kopp HG, Kanz L, Hartmann JT. Kopp HG, et al. Anticancer Drugs. 2006 Sep;17(8):997-8. doi: 10.1097/01.cad.0000224453.39200.d7. Anticancer Drugs. 2006. PMID: 16940811
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.
Dörfel D, Lechner CJ, Joas S, Funk T, Gutknecht M, Salih J, Geiger J, Kropp KN, Maurer S, Müller MR, Kopp HG, Salih HR, Grünebach F, Rittig SM. Dörfel D, et al. Among authors: kopp hg. Cancer Immunol Immunother. 2018 May;67(5):775-783. doi: 10.1007/s00262-018-2129-9. Epub 2018 Feb 21. Cancer Immunol Immunother. 2018. PMID: 29468363
Targeted Treatment of Esophagogastric Cancer.
Kopp HG, Hofheinz RD. Kopp HG, et al. Oncol Res Treat. 2016;39(12):788-794. doi: 10.1159/000452877. Epub 2016 Nov 22. Oncol Res Treat. 2016. PMID: 27889780 Review.
Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma.
Kopp HG, Yildirim S, Weisel KC, Kanz L, Vogel W. Kopp HG, et al. J Cancer Res Clin Oncol. 2009 Apr;135(4):637-42. doi: 10.1007/s00432-008-0499-7. Epub 2008 Oct 22. J Cancer Res Clin Oncol. 2009. PMID: 18941780
RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia.
Schmiedel BJ, Scheible CA, Nuebling T, Kopp HG, Wirths S, Azuma M, Schneider P, Jung G, Grosse-Hovest L, Salih HR. Schmiedel BJ, et al. Among authors: kopp hg. Cancer Res. 2013 Jan 15;73(2):683-94. doi: 10.1158/0008-5472.CAN-12-2280. Epub 2012 Nov 8. Cancer Res. 2013. PMID: 23139212
116 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback